ECL vs IMA · P/E 35, rev $4.01B vs rev $9.2M
Ecolab Inc (ECL) versus ImageneBio, Inc. (IMA) — a side-by-side from cached financials, not a winner call.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
ECL currently screens at market cap $72.05B and trailing P/E 34.6. IMA currently screens at market cap $64.7M.
Not investment advice. Open the ECL and IMA stock pages for the full models.
Not investment advice.